<DOC>
	<DOCNO>NCT01182727</DOCNO>
	<brief_summary>Being obese common problem people schizophrenia . People schizophrenia likely overweight compare general population . Being overweight major risk factor develop type II diabetes . Approximately 15 % people schizophrenia type II diabetes . People type II diabetes problem body 's insulin . Insulin hormone produce body control blood sugar level . Obesity type II diabetes strong risk factor heart disease . In type II diabetes body respond insulin correctly . Obesity , type II diabetes , insulin resistance common state inflammation . Inflammation reaction body irritation , injury , infection . Salicylates non-steroidal anti-inflammatory drug . Aspirin example salicylate . These drug work decrease level inflammation body . Salicylates show decrease inflammation improve body 's response insulin . Improving body 's response insulin decrease inflammation could possibly reduce risk develop type II diabetes . Salicylates known year effective treatment diabetes . Salicylates increase body 's response insulin cause blood sugar level decrease . Many salicylate drug side effect include stomach irritation increase risk bleeding . The drug study call salsalate different salicylate . Salsalate low bleeding risk aspirin . Salsalate use treat arthritis show safe . There study use salsalate people schizophrenia . The purpose study gain experience use salsalate people schizophrenia . The study would pilot study obtain preliminary data . The study would 6-week study everyone study would receive drug salsalate . The participant study test baseline symptom schizophrenia , physical exam , EKG ( check heart function ) , side effect checklist possible side effect salsalate . The study also blood drawn measure blood sugar level , insulin level , inflammatory marker .</brief_summary>
	<brief_title>Salsalate Insulin Resistance Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<criteria>DSMIV TR diagnosis schizophrenia schizoaffective disorder Body Mass Index ( BMI ) great equal 27 kg/m2 Participant judge clinically stable Participants treat antipsychotic least 90 day receive constant therapeutic dose least 20 day prior study entry . There restriction type antipsychotic participant treat . Participants must judge competent participate inform consent process provide voluntary informed consent . Individuals aspirin allergy . Individuals preexist tinnitus . Individual anemia thrombocytopenia . Individuals ongoing infection . Individuals history autoimmune disease . Individuals peptic ulcer disease gastritis . Individuals weight loss great 5 % past 6 month . Individuals currently take immunosuppressive drug include corticosteroid . Individuals take antidiabetic agent . Individuals take nonsteroidal antiinflammatory agent ( low dose aspirin ) . Individuals organic brain disorder ; mental retardation ; medical condition whose pathology treatment would alter presentation treatment schizophrenia significantly increase risk associate propose treatment protocol . Pregnant female . Individuals meet DSMIV TR criterion alcohol substance dependence ( except nicotine ) within last 6 month . Individuals meet DSMIV TR criterion alcohol substance abuse ( except nicotine ) within last month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>salsalate</keyword>
	<keyword>obesity</keyword>
</DOC>